BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27339829)

  • 1. Opportunities and Challenges for Pancreatic Circulating Tumor Cells.
    Nagrath S; Jack RM; Sahai V; Simeone DM
    Gastroenterology; 2016 Sep; 151(3):412-26. PubMed ID: 27339829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications.
    Tjensvoll K; Nordgård O; Smaaland R
    Int J Cancer; 2014 Jan; 134(1):1-8. PubMed ID: 23447365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity Versus Label-Free Isolation of Circulating Tumor Cells: Who Wins?
    Murlidhar V; Rivera-Báez L; Nagrath S
    Small; 2016 Sep; 12(33):4450-63. PubMed ID: 27436104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells in pancreatic cancer patients: efficacy in diagnosis and value in prognosis.
    Xie ZB; Yao L; Jin C; Fu DL
    Discov Med; 2016 Sep; 22(120):121-128. PubMed ID: 27755967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
    Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation.
    Bobek V; Gurlich R; Eliasova P; Kolostova K
    World J Gastroenterol; 2014 Dec; 20(45):17163-70. PubMed ID: 25493031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer circulating tumor cells: applications for personalized oncology.
    DiPardo BJ; Winograd P; Court CM; Tomlinson JS
    Expert Rev Mol Diagn; 2018 Sep; 18(9):809-820. PubMed ID: 30099926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells.
    Yeo D; Bastian A; Strauss H; Saxena P; Grimison P; Rasko JEJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micropallet arrays for the capture, isolation and culture of circulating tumor cells from whole blood of mice engrafted with primary human pancreatic adenocarcinoma.
    Gach PC; Attayek PJ; Whittlesey RL; Yeh JJ; Allbritton NL
    Biosens Bioelectron; 2014 Apr; 54():476-83. PubMed ID: 24316450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circulating tumor cells: liquid biopsy].
    Alix-Panabières C; Pierga JY
    Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vita-Assay™ Method of Enrichment and Identification of Circulating Cancer Cells/Circulating Tumor Cells (CTCs).
    Tulley S; Zhao Q; Dong H; Pearl ML; Chen WT
    Methods Mol Biol; 2016; 1406():107-19. PubMed ID: 26820949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Microfluidic Device for Isolation of Circulating Tumor Cells from Pancreatic Cancer Blood Samples.
    Varillas JI; Chen K; Zhang J; George TJ; Hugh Fan Z
    Methods Mol Biol; 2017; 1634():33-53. PubMed ID: 28819839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of CTCs as Tumor Biomarkers.
    Lianidou ES; Markou A; Strati A
    Adv Exp Med Biol; 2015; 867():341-67. PubMed ID: 26530376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
    Zhang Y; Wang F; Ning N; Chen Q; Yang Z; Guo Y; Xu D; Zhang D; Zhan T; Cui W
    Int J Cancer; 2015 Mar; 136(5):1228-33. PubMed ID: 25042121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.
    Ankeny JS; Court CM; Hou S; Li Q; Song M; Wu D; Chen JF; Lee T; Lin M; Sho S; Rochefort MM; Girgis MD; Yao J; Wainberg ZA; Muthusamy VR; Watson RR; Donahue TR; Hines OJ; Reber HA; Graeber TG; Tseng HR; Tomlinson JS
    Br J Cancer; 2016 Jun; 114(12):1367-75. PubMed ID: 27300108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technologies for detection of circulating tumor cells: facts and vision.
    Alix-Panabières C; Pantel K
    Lab Chip; 2014 Jan; 14(1):57-62. PubMed ID: 24145967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.